We explore what it means to be human 鈥� in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
ARISTOCRAT: A randomised controlled phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma
ARISTOCRAT is a UK trial testing the use of the cannabis-based drug Sativex with the current chemotherapy treatment in treating patients with recurrent glioblastoma.
The trial is led by Professor Susan Short (Chief Investigator) at University of Leeds, in collaboration with CRCTU at the University 麻豆精选 and is funded by The Brain Tumour Charity and sponsored by the University 麻豆精选.
When cancer comes back after treatment, doctors call it a recurrence or recurrent cancer. Only patients with recurrent disease are eligible for the ARISTOCRAT trial.
Brain tumour patient Baljit Mehat (who sadly passed away this year) previously sat down with the ARISTOCRAT chief investigator, to ask some key questions. This video is for educational purposes only and is not intended to replace patient information for the trial. Patients should speak to a healthcare professional if they want more information about the trial.
Find out more about the trial and how to get involved
Information for hospitals
Please note that the trials team cannot give individuals clinical advice. Patients and their families should contact their treating doctor to discuss trials for which they may be eligible.
'World-first UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours' - University 麻豆精选 UK (3 August 2021)